Home

Platinum Partners Value Arbitrage Fund, LP

CIK 1299265 · last filed 2014-09-04

Platinum Partners Value Arbitrage Fund, LP is a corporate insider who has filed 4 SEC Form 4 insider transactions across 1 company since 2012. The most recent filing shows the insider sold $570.9K of NAVB on Sep 4, 2014. Across all open-market trades the lifetime net is −$5.6M, making them a net seller over the disclosed history. The firm reports its address in New York, NY. 12 SEC filings were submitted jointly with Platinum Management (NY) LLC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

4

Lifetime Open-Market Net

-$5.62M

Filer Profile

Reported Address
250 WEST 55TH STREET
14TH FLOOR
NEW YORK, NY 10019
Phone
(212) 582-2222
State of Incorporation
Cayman Islands
Related Filers
Platinum Management (NY) LLC — 12 joint filings, latest 2016-07-20
Platinum-Montaur Life Sciences, LLC — 12 joint filings, latest 2015-05-18
Platinum Partners Liquid Opportunity Master Fund L.P. — 11 joint filings, latest 2015-05-18
Capitol Acquisition Corp — 3 joint filings, latest 2009-02-13
GLAZER CAPITAL, LLC — same reported address
Gen IV Investment Opportunities, LLC — same reported address
LSP Investment Advisors, LLC — same reported address
Redwood Capital Management Holdings, LP — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted 10%+ Owner 937,280 $0.00 $94 -$5.62M 3 2014-09-04

Recent Filings

4 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2014-09-04 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Sell (S) −420,000 -$570.9K EDGAR
2012-11-29 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Other (J) −6,003,720 -$15.49M EDGAR
2012-11-09 NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) Delisted Mixed −1,342,704 -$5.05M EDGAR
2010-02-23 — Sell (S) −397,440 -$2.33M
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.